Department of Anesthesiology, Critical Care and Pain Medicine, "Sapienza" University of Rome, Rome, Italy.
Department of Anesthesiology and Operative Intensive Care Medicine (CCM, CVK), Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Acta Anaesthesiol Scand. 2020 Apr;64(4):494-500. doi: 10.1111/aas.13535. Epub 2020 Jan 19.
Postoperative delirium (POD) is a severe brain dysfunction. Although data indicate a high relevance, no survey has investigated the routine practice to monitor delirium outside the ICU setting after surgery. Prior to publishing of the new European Society of Anaesthesiology (ESA) guidelines on POD, an international survey was conducted to assess current practice.
European Society of Anaesthesiology-endorsed online survey; Trial Registration: NCT-identifier: 02513537.
In total, 566 respondents from 62 countries accessed, and 564 (99.6%) completed the survey (completion rate). Overall, 385 (68%) of the respondents reported that delirium is either "very relevant" or "relevant" for their daily clinical practice. In all, 38 (7%) of the respondents routinely monitor for delirium in >50% of all patients. Asked on the monitoring time point, more than half (n = 308, 55%) indicated to screen before or at recovery room discharge, 235 (42%) up to the first postoperative day, 143 (25%) up to 3 days, and 77 (14%) up to 5 postoperative days. Although there is a lack of long-term monitoring, nearly all respondents (n = 530, 94%) reported to treat delirium. Availability of EEG/EMG-based monitoring to assess the depth of anaesthesia was high in the study group (n = 547, 97%) and was used by more than one-third of the respondents to reduce risk of burst suppression (n = 189, 34%).
Although delirium is perceived as a relevant condition among anaesthesiologists, there is a high demand for implementing monitoring strategies after publishing of the POD Guideline. The survey shows that tools necessary for POD Guideline implementation are available in the centres represented by the respondents.
术后谵妄(POD)是一种严重的脑功能障碍。尽管数据表明其相关性很高,但尚无调查研究在术后 ICU 环境之外常规监测谵妄的情况。在新的欧洲麻醉学会(ESA)POD 指南发布之前,进行了一项国际调查,以评估当前的实践情况。
欧洲麻醉学会认可的在线调查;试验注册:NCT 标识符:02513537。
共有来自 62 个国家的 566 名受访者访问了该调查,并完成了 564 项调查(完成率为 99.6%)。总体而言,385 名(68%)受访者报告说,谵妄与他们的日常临床实践“非常相关”或“相关”。共有 38 名(7%)受访者常规监测超过 50%的所有患者的谵妄情况。在监测时间点方面,超过一半(n=308,55%)的受访者表示在恢复室出院前或在恢复室出院时进行筛查,235 名(42%)受访者在术后第一天进行筛查,143 名(25%)在术后 3 天进行筛查,77 名(14%)在术后 5 天进行筛查。尽管缺乏长期监测,但几乎所有受访者(n=530,94%)都报告对谵妄进行了治疗。研究组中,脑电图/肌电图监测评估麻醉深度的可用性很高(n=547,97%),超过三分之一的受访者(n=189,34%)使用该监测来降低爆发抑制的风险。
尽管麻醉医师认为谵妄是一种相关病症,但在 POD 指南发布后,对实施监测策略的需求很高。该调查表明,接受调查的中心都具备实施 POD 指南所需的工具。